Fig. 3From: Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancerThe correlation of CPT2 expression with CRC clinicopathological features. A The Kaplan-Meier survival curve for patients in the low- and high- risk groups of CPT2 (i) and ASCL6 (ii) in the TCGA-CRC cohort. B Kaplan-Meier curves for CPT2 in CRC cohort in GEPIA. C The distribution of clinicopathological characteristics of CPT2Back to article page